CN110910956B - 单核苷酸多态性检测汉族人群吸烟成瘾方法 - Google Patents
单核苷酸多态性检测汉族人群吸烟成瘾方法 Download PDFInfo
- Publication number
- CN110910956B CN110910956B CN201911148956.5A CN201911148956A CN110910956B CN 110910956 B CN110910956 B CN 110910956B CN 201911148956 A CN201911148956 A CN 201911148956A CN 110910956 B CN110910956 B CN 110910956B
- Authority
- CN
- China
- Prior art keywords
- single nucleotide
- nucleotide polymorphism
- addiction
- sites
- smoking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010012335 Dependence Diseases 0.000 title claims abstract description 78
- 239000002773 nucleotide Substances 0.000 title claims abstract description 54
- 125000003729 nucleotide group Chemical group 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims abstract description 16
- 235000019504 cigarettes Nutrition 0.000 title claims abstract description 5
- 230000000391 smoking effect Effects 0.000 claims abstract description 75
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 65
- 238000012163 sequencing technique Methods 0.000 claims abstract description 21
- 238000003205 genotyping method Methods 0.000 claims abstract description 19
- 238000012164 methylation sequencing Methods 0.000 claims abstract description 13
- 230000008827 biological function Effects 0.000 claims abstract description 7
- 235000019505 tobacco product Nutrition 0.000 claims abstract description 6
- 239000008280 blood Substances 0.000 claims abstract description 3
- 210000004369 blood Anatomy 0.000 claims abstract description 3
- 238000004458 analytical method Methods 0.000 claims description 22
- 230000011987 methylation Effects 0.000 claims description 17
- 238000007069 methylation reaction Methods 0.000 claims description 17
- 238000012098 association analyses Methods 0.000 claims description 16
- 239000000523 sample Substances 0.000 claims description 16
- 238000001514 detection method Methods 0.000 claims description 10
- 238000012216 screening Methods 0.000 claims description 10
- 229960002715 nicotine Drugs 0.000 claims description 8
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 8
- 230000014509 gene expression Effects 0.000 claims description 7
- 101000741396 Chlamydia muridarum (strain MoPn / Nigg) Probable oxidoreductase TC_0900 Proteins 0.000 claims description 6
- 101000741399 Chlamydia pneumoniae Probable oxidoreductase CPn_0761/CP_1111/CPj0761/CpB0789 Proteins 0.000 claims description 6
- 101000741400 Chlamydia trachomatis (strain D/UW-3/Cx) Probable oxidoreductase CT_610 Proteins 0.000 claims description 6
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 6
- 238000011160 research Methods 0.000 claims description 6
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 5
- 238000003908 quality control method Methods 0.000 claims description 5
- 238000002474 experimental method Methods 0.000 claims description 4
- 230000004060 metabolic process Effects 0.000 claims description 4
- 239000002858 neurotransmitter agent Substances 0.000 claims description 4
- 239000000779 smoke Substances 0.000 claims description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims description 4
- 238000012417 linear regression Methods 0.000 claims description 3
- 238000011002 quantification Methods 0.000 claims description 3
- 102000005962 receptors Human genes 0.000 claims description 3
- 108020003175 receptors Proteins 0.000 claims description 3
- 238000011144 upstream manufacturing Methods 0.000 claims description 3
- 229940035893 uracil Drugs 0.000 claims description 3
- 102100036846 C-C motif chemokine 21 Human genes 0.000 claims description 2
- 102000009666 Cytochrome P-450 CYP2B6 Human genes 0.000 claims description 2
- 108010020070 Cytochrome P-450 CYP2B6 Proteins 0.000 claims description 2
- 102100038942 Glutamate receptor ionotropic, NMDA 3A Human genes 0.000 claims description 2
- 102000017679 HTR3A Human genes 0.000 claims description 2
- 102000017678 HTR3B Human genes 0.000 claims description 2
- 101000761343 Homo sapiens 5-hydroxytryptamine receptor 3A Proteins 0.000 claims description 2
- 101000964058 Homo sapiens 5-hydroxytryptamine receptor 3B Proteins 0.000 claims description 2
- 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 claims description 2
- 101000603180 Homo sapiens Glutamate receptor ionotropic, NMDA 3A Proteins 0.000 claims description 2
- 101000782865 Homo sapiens Neuronal acetylcholine receptor subunit alpha-2 Proteins 0.000 claims description 2
- 101000745167 Homo sapiens Neuronal acetylcholine receptor subunit alpha-4 Proteins 0.000 claims description 2
- 101000822103 Homo sapiens Neuronal acetylcholine receptor subunit alpha-7 Proteins 0.000 claims description 2
- 101000726901 Homo sapiens Neuronal acetylcholine receptor subunit beta-2 Proteins 0.000 claims description 2
- 102100035585 Neuronal acetylcholine receptor subunit alpha-2 Human genes 0.000 claims description 2
- 102100039909 Neuronal acetylcholine receptor subunit alpha-4 Human genes 0.000 claims description 2
- 102100021511 Neuronal acetylcholine receptor subunit alpha-7 Human genes 0.000 claims description 2
- 102100030912 Neuronal acetylcholine receptor subunit beta-2 Human genes 0.000 claims description 2
- 239000013614 RNA sample Substances 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 2
- 230000035622 drinking Effects 0.000 claims description 2
- 229940113082 thymine Drugs 0.000 claims description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims 4
- 229940104302 cytosine Drugs 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 5
- 230000035772 mutation Effects 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000005586 smoking cessation Effects 0.000 description 3
- 238000003766 bioinformatics method Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000010219 correlation analysis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000009660 Cholinergic Receptors Human genes 0.000 description 1
- 108010009685 Cholinergic Receptors Proteins 0.000 description 1
- 101000875170 Homo sapiens Cytochrome P450 2A6 Proteins 0.000 description 1
- 101000745175 Homo sapiens Neuronal acetylcholine receptor subunit alpha-5 Proteins 0.000 description 1
- 101000726905 Homo sapiens Neuronal acetylcholine receptor subunit beta-3 Proteins 0.000 description 1
- 102100039907 Neuronal acetylcholine receptor subunit alpha-5 Human genes 0.000 description 1
- 102100030911 Neuronal acetylcholine receptor subunit beta-3 Human genes 0.000 description 1
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/40—Population genetics; Linkage disequilibrium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Wood Science & Technology (AREA)
- Ecology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911148956.5A CN110910956B (zh) | 2019-11-21 | 2019-11-21 | 单核苷酸多态性检测汉族人群吸烟成瘾方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911148956.5A CN110910956B (zh) | 2019-11-21 | 2019-11-21 | 单核苷酸多态性检测汉族人群吸烟成瘾方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110910956A CN110910956A (zh) | 2020-03-24 |
CN110910956B true CN110910956B (zh) | 2024-03-22 |
Family
ID=69818517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911148956.5A Active CN110910956B (zh) | 2019-11-21 | 2019-11-21 | 单核苷酸多态性检测汉族人群吸烟成瘾方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110910956B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111518896B (zh) * | 2020-06-28 | 2023-09-26 | 云南中烟工业有限责任公司 | 用于检测尼古丁依赖相关的snp位点的引物组、应用、产品及方法 |
CN111893174A (zh) * | 2020-07-23 | 2020-11-06 | 上海联吉医学检验所有限公司 | 一种脑卒中用药基因位点联合检测的方法及其引物组、探针组和试剂盒 |
CN113462772B (zh) * | 2021-09-03 | 2021-11-16 | 中南大学湘雅医院 | 一种用于检测尼古丁依赖性相关的snp位点的引物组以及应用 |
CN117153250B (zh) * | 2023-10-31 | 2024-03-01 | 中日友好医院(中日友好临床医学研究所) | 烟草依赖个体化干预基因变异位点筛选方法及试剂盒 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101437960A (zh) * | 2006-03-01 | 2009-05-20 | 佩勒根科学有限公司 | 成瘾性的标志物 |
CN101845501A (zh) * | 2010-05-18 | 2010-09-29 | 孟涛 | 一种复杂疾病易感性综合遗传分析方法 |
CN107653311A (zh) * | 2017-09-07 | 2018-02-02 | 中国医学科学院阜外医院 | 与血脂水平相关的单核苷酸多态性rs4883263检测系统及相关应用 |
CN107653342A (zh) * | 2016-12-28 | 2018-02-02 | 成都百泰赛维生物科技有限公司 | 一种pcr法检测汉族人hdv病毒的方法 |
CN108251520A (zh) * | 2018-01-31 | 2018-07-06 | 杭州同欣基因科技有限公司 | 一种基于高通量测序技术的吸烟成瘾风险预测方法及戒烟指导方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110294680A1 (en) * | 2008-02-22 | 2011-12-01 | Duke University | Methods and compositions for predicting success in addictive substance cessation and for predicting a risk of addiction |
ES2426517B1 (es) * | 2012-04-20 | 2014-05-14 | Genetracer Biotech S.L | Método para predecir la seguridad de un tratamiento farmacológico |
-
2019
- 2019-11-21 CN CN201911148956.5A patent/CN110910956B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101437960A (zh) * | 2006-03-01 | 2009-05-20 | 佩勒根科学有限公司 | 成瘾性的标志物 |
CN101845501A (zh) * | 2010-05-18 | 2010-09-29 | 孟涛 | 一种复杂疾病易感性综合遗传分析方法 |
CN107653342A (zh) * | 2016-12-28 | 2018-02-02 | 成都百泰赛维生物科技有限公司 | 一种pcr法检测汉族人hdv病毒的方法 |
CN107653311A (zh) * | 2017-09-07 | 2018-02-02 | 中国医学科学院阜外医院 | 与血脂水平相关的单核苷酸多态性rs4883263检测系统及相关应用 |
CN108251520A (zh) * | 2018-01-31 | 2018-07-06 | 杭州同欣基因科技有限公司 | 一种基于高通量测序技术的吸烟成瘾风险预测方法及戒烟指导方法 |
Non-Patent Citations (1)
Title |
---|
Genetic Association of the CHRNA6 and CHRNB3 Genes with Tobacco Dependence in a Nationally Representative Sample;Nicole R Hoft等;Neuropsychopharmacology;第34卷;698-706 * |
Also Published As
Publication number | Publication date |
---|---|
CN110910956A (zh) | 2020-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110910956B (zh) | 单核苷酸多态性检测汉族人群吸烟成瘾方法 | |
Rodin et al. | The landscape of somatic mutation in cerebral cortex of autistic and neurotypical individuals revealed by ultra-deep whole-genome sequencing | |
Nakka et al. | Characterization of prevalence and health consequences of uniparental disomy in four million individuals from the general population | |
Quach et al. | Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits | |
Hwang et al. | Dynamic regulation of RNA editing in human brain development and disease | |
Suter et al. | Maternal tobacco use modestly alters correlated epigenome-wide placental DNA methylation and gene expression | |
Abbasi et al. | Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes | |
Kim et al. | A highly annotated whole-genome sequence of a Korean individual | |
Bacchelli et al. | A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants | |
Sangaré et al. | Genetics of low spinal muscular atrophy carrier frequency in sub‐Saharan Africa | |
TW200847056A (en) | Genetic analysis systems and methods | |
Al Khleifat et al. | Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis | |
Liskova et al. | Heterozygous deletions at the ZEB1 locus verify haploinsufficiency as the mechanism of disease for posterior polymorphous corneal dystrophy type 3 | |
JP2009528063A (ja) | 依存症に対するマーカー | |
Brassat et al. | Familial factors influence disability in MS multiplex families | |
Zhao et al. | Genome-wide association studies detects candidate genes for wool traits by re-sequencing in Chinese fine-wool sheep | |
Lee et al. | A case‐control study of the association of the polymorphisms and haplotypes of DNA ligase I with lung and upper‐aerodigestive‐tract cancers | |
Roostaei et al. | Proximal and distal effects of genetic susceptibility to multiple sclerosis on the T cell epigenome | |
Lago-Docampo et al. | Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients | |
Eusebi et al. | Aggressive behavior in cattle is associated with a polymorphism in the MAOA gene promoter | |
Clukay et al. | DNA methylation of methylation complex genes in relation to stress and genome‐wide methylation in mother–newborn dyads | |
Van Eyk et al. | Targeted resequencing identifies genes with recurrent variation in cerebral palsy | |
Yingjun et al. | Copy number variations independently induce autism spectrum disorder | |
Pérez-Rubio et al. | Polymorphisms in HTR2A and DRD4 predispose to smoking and smoking quantity | |
Tajima et al. | Blood lipid-related low-frequency variants in LDLR and PCSK9 are associated with onset age and risk of myocardial infarction in Japanese |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Mingding Inventor after: Liu Qiang Inventor after: Ma Yunlong Inventor before: Liu Qiang Inventor before: Ma Yunlong Inventor before: Li Mingding |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240223 Address after: Room 901, 9th Floor, Building 9, Dongsheng Huigu, 1299 Kehai Avenue, Anchang Street, Keqiao District, Shaoxing City, Zhejiang Province, 312000 Applicant after: Zhejiang Maiyata Bacterial Testing Intelligent Technology Co.,Ltd. Country or region after: China Address before: Room 105, Unit 1, Building 1, No. 9 Longbao Street, Yingze District, Taiyuan City, Shanxi Province, 030000 Applicant before: Liu Qiang Country or region before: China Applicant before: Ma Yunlong |
|
GR01 | Patent grant | ||
GR01 | Patent grant |